Early life and education
Following her medical training, Hamburg moved to Washington, D.C., to begin her career in public service. She served in several roles, including Assistant Director of the National Institute of Allergy and Infectious Diseases
, National Institutes of Health
. In 1991 Hamburg was appointed Commissioner of the New York City Department of Health and Mental Hygiene
, where she served for six years, working first for Mayor David Dinkins
and then-Mayor Rudy Giuliani
. During her tenure, she worked on improved services for women and children, a needle-exchange program to reduce HIV transmission, a program to curtail the resurgence and spread of tuberculosis, and the nation's first public health bioterrorism preparedness program.
In 1997, President Bill Clinton
appointed Hamburg as Assistant Secretary for Planning and Evaluation at the U.S. Department of Health and Human Services
. She served in this policy role until 2001 when she became the founding Vice President for Biological Programs and later the Senior Scientist for the Nuclear Threat Initiative
a foundation dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. In that role, Hamburg spearheaded efforts to prevent, detect, and respond to both naturally occurring and deliberately caused biological threats.
Hamburg (center right) visits a California rice farm in 2013 while Commissioner of the FDA
Hamburg was the longest-serving FDA commissioner since David A. Kessler
, and was the second woman to hold the position.
In April 2015 Hamburg was appointed Foreign Secretary of the National Academy of Medicine
In December 2016, Hamburg was named president-elect for the AAAS.
She serves a three-year term as an officer and member of the Executive Committee of the AAAS Board of Directors beginning in February 2017.
Awards and recognition
named her as one of the world's 100 most powerful women multiple times, most recently in 2014 (#51).
- American Museum of Natural History, member of the board of trustees
- Bill and Melinda Gates Foundation, member of the Global Health Scientific Advisory Committee
- Coalition for Epidemic Preparedness Innovations (CEPI), chair of the Joint Coordinating Group
- Commonwealth Fund, member of the board of directors
- Centre of Regulatory Excellence (CoRE), Duke–NUS Medical School, member of the advisory board
- Department of Global Health, University of Washington, member of the external advisory board
- GAVI Alliance, member of the board
- Harvard Medical School, member of the board of fellows
- Harvard University, member of the global advisory council
- Nuclear Threat Initiative (NTI), member of the board of directors
- Simons Foundation, member of the scientific advisory board for the Autism Research Initiative
- Urban Institute, member of the board of trustees
- Wellcome Trust, member of the Strategic Advisory Board on Vaccines and Drug-resistant Infections
- World Dementia Council, member of the board
Hamburg is married to Peter Fitzhugh Brown
, a computer scientist and artificial intelligence
expert. Brown is the chief executive officer of Renaissance Technologies
Renaissance Technologies employees were collectively the top donors to President Donald Trump's 2016 campaign
and collectively the third largest donors to Hillary Clinton,
giving $15.5 million and $16.5 million respectively.
- Hamburg MA. (2012). Science and regulation: FDA's approach to regulation of products of nanotechnology. Science. Vol. 336(6079):299-300
- Hamburg MA. (2010). Shattuck lecture: Innovation, regulation, and the FDA. New England Journal of Medicine. Vol. 363(23):2228-32
- Hamburg MA, Collins FS. (2010). The path to personalized medicine. New England Journal of Medicine. Vol. 363(4):301-4
- Hamburg MA, Sharfstein JM. (2009). The FDA as a public health agency. New England Journal of Medicine. Vol. 360(24):2493-5
- Hamburg, M.A., Levi, J., Elliott, K. and Williams, L. (2008). Germs go global: why emerging infectious diseases are a threat to America. Trust for America's Health
- Hamburg, M.A. (2007). Public health and China: emerging disease and challenges to health. In: K.M. Campbell and W. Darsie (eds.). China's March on the 21st century: A Report of the Aspen Srategy Group. Washington DC: The Aspen Institute, pp 61–76
- Hamburg, M.A. (2002). Bioterrorism: responding to an emerging threat. Trends in Biotechnology. Vol. 20(7): 296-298
- Hamburg, M.A. (2002). Preparing for and preventing bioterrorism. Issues in Science and Technology. Vol. 18(2): 27-30
- Hamburg, M.A. (2001). Challenges facing public health agencies. Public Health Reports. Vol. 116(Supplement 2): 59-63
- Frieden, T.R., Fujiwara, P.I., Washko, R.M. and Hamburg, M.A. (1995) Turning the tide on tuberculosis: the New York City experience. New England Journal of Medicine, Vol. 333: 229-233
- Hamburg, M.A. and Frieden, T.R. (1994). Tuberculosis transmission in the 1990s (editorial). The New England Journal of Medicine, Vol. 330, No. 24: 1750-1751
- Hamburg, M.A. and Fauci, A.S. (Spring 1989). AIDS: the challenge to biomedical research. Deadalus, Vol. 118, No. 2: 19-39
- Hamburg, M. and Tallman, J.F. (1981). Chronic morphine administration increases the apparent number of alpha-2 adrenergic receptors in rat brain. Nature 291: 493-495
- Smolinski, M.S., Hamburg, M.A., and Lederberg, J., Editors (2003) Microbial Threats to Health: Emergence, Detection, and Response. Washington D.C.: The National Academies Press
- "Zerhouni E and Hamburg M. (2016). The need for global regulatory harmonization: A public health imperative. Science Translational Medicine. Vol 8(338)"
- ^ "PN530 - Nomination of Margaret Ann Hamburg for Department of Health and Human Services, 105th Congress (1997-1998)". www.congress.gov. 30 October 1997.
- ^ "PN249 - Nomination of Piyush Jindal for Department of Health and Human Services, 107th Congress (2001-2002)". www.congress.gov. 25 May 2001.
- ^ "Organization and Governance". American Association for the Advancement of Science. Retrieved 2019-04-16.
- ^ FDA head Margaret Hamburg to resign in March; Ostroff to be acting chief (Washington Post article-February 5, 2015)
- ^ "Biography of Margaret A. Hamburg, M.D."U.S. Food & Drug Administration.
- ^ Pugh, Tony (5 February 2015). "FDA commissioner Margaret Hamburg to step down in March". McClatchy DC. McClatchy Washington Bureau. Retrieved 19 September 2016.
- ^ Gardiner Harris (11 March 2009). "Ex-New York Health Commissioner Is F.D.A. Pick". The New York Times. Retrieved 2009-03-12.
- ^ Gratzer, David (2009-05-21). "FDA commissioner". US FDA. Retrieved 2010-09-12.
- ^ "Biography of Margaret A. Hamburg, M.D."U.S. Food & Drug Administration. U.S. Food & Drug Administration.
- ^ "Margaret A. Hamburg Appointed as Institute of Medicine Foreign Secretary". nationalacademies.org. The National Academies of Sciences, Engineering, and Medicine. April 6, 2015. Retrieved April 23, 2016.
- ^ Korte, Andrea. "Margaret Hamburg Selected to Serve as AAAS President-Elect". AAAS. AAAS. Retrieved 9 January 2017.
- ^ "2011 Trumpeter Recipient: Dr. Margaret Hamburg". Retrieved 11 March 2015.
- ^ "2011 Foremothers & Health Policy Hero Awards". National Research Center for Women & Families. Archived from the original on 14 May 2011. Retrieved 19 November 2012.
- ^ "2016 ACCP Annual Meeting". American College of Clinical Pharmacology.
- ^ "The Academy Medal for Distinguished Contributions in Health Policy". The New York Academy of Medicine.
- ^ Office of Research on Women's Health (25 March 2004). "Dr. Margaret Hamburg". Changing the Face of Medicine. National Institutes of Health. Retrieved 2009-03-06.
- ^ "The World's 100 Most Powerful Women". Forbes. Retrieved 26 June 2014.
- ^ Leadership Alnylam Pharmaceuticals.
- ^ "Board of Trustees". American Museum of Natural History. American Museum of Natural History. Retrieved 19 September 2016.
- ^ "Scientific Advisory Committee". Bill & Melinda Gates Foundation. Bill & Melinda Gates Foundation. Retrieved 19 September 2016.
- ^ "Margaret A. Hamburg, M.D., Elected to Commonwealth Fund Board of Directors". The Commonwealth Fund. The Commonwealth Fund.
- ^  Duke–NUS Medical School.
- ^ External Advisory Board: Margaret Hamburg Department of Global Health, University of Washington.
- ^ Board members GAVI Alliance
- ^ "Harvard Medical School Board of Fellows". Harvard Medical School. Harvard Medical School. Retrieved 19 September 2016.
- ^ Board of Directors Nuclear Threat Initiative (NTI).
- ^ Scientific Advisory Board for the Autism Research Initiative: Margaret Hamburg Simons Foundation.
- ^ "Board of Trustees". Urban Institute. Urban Institute. 2017-10-25.
- ^ Strategic Advisory Board on Vaccines and Drug-resistant Infections Wellcome Trust.
- ^ Independent Task Force Report No. 78 – Improving Pandemic Preparedness: Lessons From COVID-19 Council on Foreign Relations, October 2020.
- ^ Call to Action: CSIS-LSHTM High-Level Panel on Vaccine Confidence and Misinformation, October 19, 2020 Center for Strategic and International Studies (CSIS).
- ^ Streett, Laura (February 11, 2014). "Vassar's First Black Students". The Gargoyle Bulletin. Vassar College. Retrieved April 23, 2016.
- ^ Peart, Karen N. (May 27, 2011). "School of Medicine honors its first African-American women graduates". Yale News. Yale University. Retrieved April 23, 2016.
- ^ "New AAAS President Emphasizes Science as Public Service". AAAS - The World's Largest General Scientific Society. 2018-02-22. Retrieved 2018-09-05.
- ^ Lederberg, Joshua (1983-07-29). "David A. Hamburg: President-Elect of AAAS". Science. 221 (4609): 431–432. Bibcode:1983Sci...221..431L. doi:10.1126/science.221.4609.431. ISSN 0036-8075. PMID 17755464.
- ^ Patterson, Scott; Strasburg, Jenny. "Pioneering Fund Stages Second Act". Wall Street Journal. Retrieved 19 December 2017.
- ^ "Top Contributors, federal election data for Donald Trump, 2016 cycle". Open Secrets. Retrieved 19 December 2017.
- ^ "Top Contributors, federal election data for Hillary Clinton, 2016 cycle". Open Secrets. Retrieved 19 December 2017.
Last edited on 8 May 2021, at 12:29
Content is available under CC BY-SA 3.0
unless otherwise noted.